TCL Archive FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts October 9, 1981
TCL Archive Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision December 2, 2011
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Cancer Genetics Network approved By NCI Advisors, To Start With 8 Centers November 29, 1996
TCL Archive FY09 Proposal for NIH Flat. NCI “Bypass Budget” Makes Case for $6 Billion. February 8, 2008
